Neurodegenerative Disorders Journals Collection

IOS Press From Bench to Bedside

 

Presenting the 
NEURODEGENERATIVE DISORDERS JOURNALS COLLECTION

The IOS Press Neurodegenerative Disorders Journals Collection includes 4 international peer-reviewed journals dedicated to advancing research, identifying preventive methods, improving diagnosis and treatment and working towards finding a cure for patients suffering from neurodegenerative disorders.

The pricing for this collection enables your library to offer your user community full online access to 4 important journals at a discount price – more than 2,000 new articles per year plus ALL backfiles!

TAKE ADVANTAGE OF SUBSTANTIAL DISCOUNTS WHEN SUBSCRIBING TO MULTIPLE TITLES FROM THE COLLECTION.

Contact us to obtain a quote.


For general enquiries, our sales team is available to discuss the 
IOS Press Neurodegenerative Disorders Journals Collection,
including pricing, free trials or other options to suit your library best.

North America
Michael Gruenberg
+1 516 965 8454
gruenbergconsulting@gmail.com
sales@iospress.com

Outside North America
sales@iospress.nl 


Journal of Alzheimer’s Disease
j-alz.com

The Journal of Alzheimer’s Disease (JAD) is dedicated to providing an open forum for original research that will help expedite our fundamental understanding of Alzheimer’s disease. Groundbreaking research that has appeared in the journal includes novel therapeutic targets, mechanisms of disease and clinical trial outcomes. JAD is the most highly cited journal dedicated to the field of Alzheimer’s disease research.*

Editor-in-Chief: George Perry, PhD, University of Texas, San Antonio

 

 

Impact Factor: 3.909*
Indexed in Medline, Web of Science, Scopus
24 issues per year
ISSN 1875-8908

 

JPD

Journal of Parkinson’s Disease
journalofparkinsonsdisease.com

Celebrating its 10th anniversary in 2020, JPD is designed to promote the exchange of ideas and disseminate original research in basic sciences, translational research, and clinical medicine that will expedite our fundamental understanding and improve treatment of Parkinson’s disease. Now in partnership with The Cure Parkinson’s Trust and the World Parkinson Coalition. 

Editors-in-Chief: Patrik Brundin, MD, PhD, Van Andel Research Institute,
and Bas Bloem, MD, PhD, Radboud University Nijmegen Medical Centre

Impact Factor: 5.178*
Indexed in Medline, Web of Science, Scopus
4 issues per year
ISSN 1877-718X

 

JHD

Journal of Huntington’s Disease

Facilitates progress in understanding the genetics, molecular correlates, pathogenesis, pharmacology, diagnosis and treatment of Huntington’s disease and related disorders. Now featuring the Clinical Trials Corner.

Editors-in-Chief: Blair R. Leavitt, MD, MC, The University of British Columbia, and Leslie M. Thompson, PhD, University of California

 

Indexed in Medline, Web of Science: Emerging Sources Citation Index, Scopus
4 issues per year
ISSN 1879-6400

 

JND

Journal of Neuromuscular Diseases

Facilitates progress in understanding the genetics, molecular correlates, pathogenesis, pharmacology, diagnosis and treatment of neuromuscular diseases. In partnership with TREAT-NMD.

Editors-in-Chief: Carsten G. Bönnemann, MD, National Institute of Neurological Disorders and Stroke/NIH, and Hanns Lochmüller, MD, University of Ottawa

 

Indexed in Medline, Scopus
4 issues per year
ISSN 2214-3602

 

PLUS AVAILABLE OPEN ACCESS

jadr_17

Journal of Alzheimer’s Disease Reports
An Open Access Journal

Dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer’s disease. The editorial leadership of JAD and JADR is working closely together to provide the AD community with greater and faster access to the breadth and depth of relevant content in this field.

Editor-in-Chief: George Perry, PhD, University of Texas, San Antonio

 

Indexed in PubMed Central, Embase, Google Scholar
1 issue per year
ISSN 2542-4823

 

*Journal Citation Reports (Source Clarivate, 2020)